0.4145
0.0011 (0.27%)
0.0011 (0.27%)
Upgrade to Real-Time
Regular Market
| Volume | 585,037 |
|
|||||
| News | - | ||||||
| Day High | 0.415 | Low High |
|||||
| Day Low | 0.4062 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Akebia Therapeutics Inc | AKBA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0011 | 0.27% | 0.4145 | 10:43:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4093 | 0.4062 | 0.415 | 0.4134 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,254 | 585,037 | $ 0.4124859 | $ 241,320 | - | 0.30 - 3.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:43:42 | 100 | $ 0.4145 | USD |
Period:
Draw Mode:
Akebia Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 76.21M | 183.85M | 181.87M | $ 213.58M | $ -117.55M | -1.70 | -0.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1.18M | 2.40% |
Akebia Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AKBA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3979 | 0.42 | 0.3801 | 0.4067508 | 3,871,119 | 0.0166 | 4.17% |
| 1 Month | 0.4196 | 0.4585 | 0.365 | 0.4031686 | 4,223,631 | -0.0051 | -1.22% |
| 3 Months | 0.33 | 0.5139 | 0.30 | 0.3831631 | 10,049,398 | 0.0845 | 25.61% |
| 6 Months | 1.77 | 2.93 | 0.30 | 0.7078555 | 10,357,600 | -1.36 | -76.58% |
| 1 Year | 2.50 | 3.35 | 0.30 | 1.08 | 6,449,357 | -2.09 | -83.42% |
| 3 Years | 4.45 | 13.78 | 0.30 | 2.73 | 4,457,374 | -4.04 | -90.69% |
| 5 Years | 14.69 | 20.25 | 0.30 | 3.27 | 2,960,236 | -14.28 | -97.18% |
Akebia Therapeutics Description
| Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. |